The Factors such as the rising incidence of target infectious diseases and genetic disorders; increasing investments, funds, and grants; technological advancements in PCR technologies; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project are driving the growth of this market. However, the high instrument costs—especially that of dPCR—and the technical limitations of PCR have restricted their greater use.
According to the new market research report Digital PCR and qPCR Market is projected to reach $7.6 billion by 2025 , at a CAGR of 9.0% between 2020 and 2025.
The clinical applications segment is estimated to dominate the qPCR applications market in 2020. Based on application, the market is categorized into clinical applications (Infectious Disease Testing, Oncology Testing, Blood Screening, Transplant Diagnostics and Other Clinical Applications), research applications and forensic applications. The key factors driving the market growth of cclinical applications segment include the growing usage of qPCR in disease diagnosis, rising incidence of infectious and genetic diseases, and growing public emphasis on early & effective disease diagnosis & treatment.
The prominent players operating in the dPCR and qPCR market are Bio-Rad Laboratories Inc. (US), Thermo Fisher Scientific (US) and F. Hoffmann-La Roche, Ltd. (Switzerland).
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204